Related Experiment Video
Updated: Aug 28, 2026

One-step Negative Chromatographic Purification of Helicobacter pylori Neutrophil-activating Protein Overexpressed in Escherichia coli in Batch Mode
Published on: June 18, 2016
Non-nonsteroidal anti-inflammatory drug, nonmalignant gastric ulcers
1Division of Gastroenterology, Hepatology, and Nutrition, University of Utah School of Medicine, Salt Lake City, USA.
Abstract:
The vast majority of gastric ulcers are owing to H. pylori infection or NSAID use. There are, however, uncommon causes of gastric ulceration that should be considered in the absence of these factors. Careful endoscopic evaluation of the ulcer associated with adequate biopsy specimens can provide the diagnosis in the vast majority of patients. All gastric ulcers should be evaluated by endoscopy and biopsy to rule out a possible malignancy. When adequate tissue samples are obtained the accuracy for diagnosis of gastric cancer is 99%. The prior recommendation of routine endoscopic follow up for gastric ulcers does not appear to be necessary. Repeat endoscopy should be reserved for patients whose initial endoscopic evaluation was inadequate or suspicious for malignancy, and those with refractory ulcers.
Related Concept Videos
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Drugs for Treatment of Ulcerative Colitis in IBD
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
